Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin...

  • Main
  • 2020 / 08
  • Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin...
Applied Health Economics and Health Policy 2020 / 08

Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus

Hu, Shanshan, Deng, Xun, Ma, Yanjiao, Li, Zhilei, Wang, Yuhang, Wang, Yong
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Applied Health Economics and Health Policy
DOI:
10.1007/s40258-020-00603-7
Date:
August, 2020
File:
PDF, 1.48 MB
2020
Conversion to is in progress
Conversion to is failed